MLICM
LAZ icon

Metropolitan Life Insurance Company (MetLife)’s Lazard LAZ Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LAZ Stock Details LAZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,994
Closed -$87K – 2481
2021
Q4 		$87K Buy
1,994
+5
+0.3% +$234 ﹤0.01% 2551
2021
Q3 		$91.1K Sell
1,989
-117
-6% -$5.46K ﹤0.01% 2574
2021
Q2 		$95.3K Buy
2,106
+64
+3% +$2.94K ﹤0.01% 2607
2021
Q1 		$88.8K Buy
2,042
+79
+4% +$3.36K ﹤0.01% 2456
2020
Q4 		$83K Sell
1,963
-61
-3% -$2.31K ﹤0.01% 2422
2020
Q3 		$66.9K Sell
2,024
-29
-1% -$893 ﹤0.01% 2421
2020
Q2 		$58.8K Sell
2,053
-2,158
-51% -$58.5K ﹤0.01% 2484
2020
Q1 		$99.2K Sell
4,211
-83
-2% -$3.07K ﹤0.01% 2034
2019
Q4 		$172K Sell
4,294
-123
-3% -$4.65K ﹤0.01% 2029
2019
Q3 		$155K Sell
4,417
-3,555
-45% -$126K ﹤0.01% 2056
2019
Q2 		$274K Sell
7,972
-178
-2% -$6.38K ﹤0.01% 1677
2019
Q1 		$295K Sell
8,150
-267
-3% -$10K 0.01% 1649
2018
Q4 		$311K Sell
8,417
-24
-0.3% -$958 0.01% 1533
2018
Q3 		$406K Sell
8,441
-188
-2% -$9.35K 0.01% 1513
2018
Q2 		$422K Buy
8,629
+396
+5% +$21K 0.01% 1436
2018
Q1 		$433K Buy
8,233
+1
+0% +$55 0.01% 1371
2017
Q4 		$432K Sell
8,232
-271
-3% -$13K 0.01% 1388
2017
Q3 		$385K Buy
8,503
+449
+6% +$19.9K ﹤0.01% 1860
2017
Q2 		$373K Buy
8,054
+3,707
+85% +$166K ﹤0.01% 1908
2017
Q1 		$200K Hold
4,347
– – ﹤0.01% 2266
2016
Q4 		$179K Sell
4,347
-126
-3% -$4.89K ﹤0.01% 2413
2016
Q3 		$163K Sell
4,473
-91
-2% -$3.18K ﹤0.01% 2456
2016
Q2 		$136K Buy
+4,564
New +$158K ﹤0.01% 2558
2014
Q3 		– Sell
-8,539
Closed -$431K – 2700
2014
Q2 		$431K Sell
8,539
-274
-3% -$13.5K ﹤0.01% 1943
2014
Q1 		$415K Hold
8,813
– – ﹤0.01% 1942
2013
Q4 		$399K Hold
8,813
– – ﹤0.01% 1971
2013
Q3 		$317K Sell
8,813
-118
-1% -$4.19K ﹤0.01% 2066
2013
Q2 		$287K Buy
+8,931
New +$299K ﹤0.01% 2080

Other funds holding LAZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RAM
RWC Asset Management London, United Kingdom $2.64B AUM 33.18% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LAZ Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Lazard (LAZ) in Q1 2022, closing a stake of 1,994 shares — an estimated $87K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LAZ in Q2 2013 and held it in 28 quarters. The position peaked at $433K in Q1 2018. 234 funds tracked by Wall St. Rank hold LAZ as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Lazard position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,994 Lazard shares in Q1 2022, an estimated $87K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Lazard in Q2 2013 and held it in 28 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Lazard position peaked at $433K in Q1 2018.
  • 234 funds tracked by Wall St. Rank held Lazard as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.